The Role of the Vaginal Microbiota in Reproductive Health: Mechanisms and Treatments

Authors

DOI:

https://doi.org/10.59282/reincisol.V3(5)1633-1654

Keywords:

Vaginal Microbiota; Reproductive Health; Mechanisms; Treatments.

Abstract

This article systematically reviews the role of vaginal microbiota in reproductive health, exploring its mechanisms of action and available treatments for vaginal dysbiosis. The main objective is to provide a comprehensive overview of how vaginal microbiota influences gynecological health and emerging therapeutic innovations. The methodology followed the PRISMA guidelines, conducting searches in academic databases such as PubMed, Scopus, and Web of Science. Studies investigating vaginal microbiota, its mechanisms of action, disruptive factors, and treatments were selected. The main findings indicate that Lactobacillus spp., predominant in a healthy vaginal microbiota, produce lactic acid and hydrogen peroxide, maintaining a low pH that inhibits pathogens. Additionally, they produce bacteriocins and compete for nutrients and space, protecting against infections. Factors such as antibiotic use, inadequate hygiene practices, and hormonal changes can disrupt this balance, leading to dysbiosis. Treatments with probiotics and prebiotics have shown effectiveness in restoring microbial balance. Vaginal microbiota transplantation (VMT) emerges as a promising alternative. The personalization of treatments based on individual microbial profiles represents a crucial future direction. This article emphasizes the importance of personalized and holistic approaches in managing vaginal health. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., & Versalovic, J. (2012). The placenta harbors a unique microbiome. *Science Translational Medicine*, 4(153), 153ra131. https://doi.org/10.1126/scitranslmed.3004240

Alves, P., Silva, M. G., & Santiago, C. (2014). Antibiotic resistance of bacteria involved in vaginal infections. *International Journal of Gynecology & Obstetrics*, 127(1), 69-72. https://doi.org/10.1016/j.ijgo.2014.04.011

Aroutcheva, A. A., Simoes, J. A., & Faro, S. (2001). Antimicrobial protein production by vaginal lactobacilli. *Journal of Reproductive Immunology*, 52(1-2), 135-143. https://doi.org/10.1016/S0165-0378(01)00105-2

Barrons, R., & Tassone, D. (2006). Use of Lactobacillus probiotics for bacterial genitourinary infections in women: A review. *Clinical Therapeutics*, 28(6), 1003-1014. https://doi.org/10.1016/j.clinthera.2006.06.004

Bested, A. C., Logan, A. C., & Selhub, E. M. (2013). Intestinal microbiota, probiotics and mental health: From Metchnikoff to modern advances: Part II - Contemporary contextual research. *Gut Pathogens*, 5(1), 3. https://doi.org/10.1186/1757-4749-5-3

Brotman, R. M., Ravel, J., Cone, R. A., & Zenilman, J. M. (2012). Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. *Sexually Transmitted Infections*, 88(5), 363-367. https://doi.org/10.1136/sextrans-2011-050319

Gajer, P., Brotman, R. M., Bai, G., Sakamoto, J., Schütte, U. M., Zhong, X., ... & Ravel, J. (2012). Temporal dynamics of the human vaginal microbiota. *Science Translational Medicine*, 4(132), 132ra52. https://doi.org/10.1126/scitranslmed.3003605

Gonzalez, R., Chernak, E., Cheng, S., & Wilkins, L. (2021). Menstrual cycle changes and their impact on the vaginal microbiota. *Journal of Women's Health*, 30(1), 13-18. https://doi.org/10.1089/jwh.2020.8443

Haahr, T., Ersbøll, A. S., Karlsen, M. A., Svare, J., Sneider, K., Hee, L., ... & Humaidan, P. (2016). Treatment of bacterial vaginosis in pregnancy and preterm delivery: a prospective cohort study. *PLOS ONE*, 11(10), e0164323. https://doi.org/10.1371/journal.pone.0164323

Hill, D. A., & Artis, D. (2014). Immunity, inflammation, and the microbiome. *Nature Reviews Immunology*, 14(12), 707-720. https://doi.org/10.1038/nri3736

Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., ... & Markowitz, L. E. (2007). The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. *Sexually Transmitted Diseases*, 34(11), 864-869. https://doi.org/10.1097/OLQ.0b013e318074e565

Published

2024-06-21

How to Cite

Salazar Mendoza, F. M. ., & Ramírez de Arellano Velázquez, D. . (2024). The Role of the Vaginal Microbiota in Reproductive Health: Mechanisms and Treatments. REINCISOL, 3(5), 1633–1654. https://doi.org/10.59282/reincisol.V3(5)1633-1654
Bookmark and Share

10.59282

reincisol